Standardization makes the observed growth response attributable to the antimicrobial concentration rather than uncontrolled differences in the test system. The inoculum, drug dilutions, and laboratory conditions provide a consistent basis for identifying the first concentration associated with no detectable growth. This improves comparison of susceptibility results across experiments and supports meaningful interpretation in infection research.
An MIC becomes more clinically informative when compared with an established susceptibility breakpoint. That comparison places the measured response into an interpretation used to support treatment selection. The MIC itself reports the concentration associated with inhibited visible growth, whereas the breakpoint provides the framework for judging susceptibility and helping researchers evaluate whether an antimicrobial may be effective against the tested organism.
Changes in MIC values can help characterize shifts in pathogen susceptibility to an antimicrobial. When results are collected and compared over time, they contribute to surveillance of emerging drug resistance. This use extends beyond a single laboratory result: MIC data can help identify changing response patterns that matter for infection research, antimicrobial evaluation, and future treatment decisions.
A broth microdilution workflow begins by preparing serial concentrations of the antimicrobial and exposing each dilution to a standardized microbial inoculum. After incubation under defined laboratory conditions, the wells or samples are examined for detectable growth. The result is determined by locating the first concentration in the dilution series without visible growth, which supplies the MIC value.
Serial dilutions create an ordered range of antimicrobial concentrations for direct comparison against the same standardized microbial inoculum. After incubation, the pattern of growth across that range shows where inhibition begins. The first concentration without detectable growth is selected rather than an average or overall trend, allowing the assay to produce a specific susceptibility measurement.
MIC testing is useful when investigators need to characterize how infection-causing organisms respond to antibiotics or other antimicrobial agents. Results can support comparisons with susceptibility breakpoints, inform treatment selection, and assess candidate agents during antimicrobial development. Repeated measurements also contribute to monitoring emerging drug resistance, linking laboratory susceptibility data with broader infection-focused research.